Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.

Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A.

Infection. 2010 Aug;38(4):269-73. doi: 10.1007/s15010-010-0031-2. Epub 2010 May 29.

2.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
4.

Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.

Bassily S, Kotkat A, Gray G, Hyams KC, Brown FM, Imam IZ, Arthur R.

Am J Trop Med Hyg. 1995 Oct;53(4):419-22.

PMID:
7485697
5.

Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.

Jafarzadeh A, Montazerifar SJ.

J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9.

PMID:
17591001
6.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
7.

Duration of protection after infant hepatitis B vaccination series.

Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR.

Pediatrics. 2014 Jun;133(6):e1500-7. doi: 10.1542/peds.2013-2940. Epub 2014 May 19.

8.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
9.
10.

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ.

Vaccine. 2007 Sep 28;25(39-40):6958-64. Epub 2007 Jul 17.

PMID:
17714836
11.

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A; Study Group..

Lancet. 2005 Oct 15-21;366(9494):1379-84.

PMID:
16226616
13.

Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K.

J Med Assoc Thai. 2002 Mar;85(3):277-82.

PMID:
12117014
14.

Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.

Jafarzadeh A, Zarei S, Shokri F.

Vaccine. 2008 Jan 10;26(2):269-76. Epub 2007 Nov 9.

PMID:
18037544
15.

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.

Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A.

Res Virol. 1997 Mar-Apr;148(2):109-14.

PMID:
9108609
16.

Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols.

Linder N, Vishne TH, Levin E, Handsher R, Fink-Kremer I, Waldman D, Levine A, Ashkenazi S, Sirota L.

Infection. 2002 Jun;30(3):136-9.

PMID:
12120937
17.

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

Duval B, Gîlca V, Boulianne N, De Wals P, Massé R, Trudeau G, De Serres G.

Pediatr Infect Dis J. 2005 Mar;24(3):213-8.

PMID:
15750456
18.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
19.

Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.

Carniel EF, Morcillo AM, Blotta MH, Da Silva MT, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, Vilela MM.

Vaccine. 2008 Jan 30;26(5):647-52. Epub 2007 Dec 7.

PMID:
18155811
20.

Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.

Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, Parkinson AJ.

Pediatr Infect Dis J. 2005 Sep;24(9):786-92.

PMID:
16148845

Supplemental Content

Support Center